[Intravesical immunotherapy with BCG vaccine in superficial carcinoma of the urinary bladder].
The authors present their experience with the use of BCG immunotherapy in the treatment of superficial bladder cancer in 42 patients as regards antitumorous effectivity. They compare BCG immunotherapy with intravesical chemotherapy and evaluate exact diagnostics before indication BCG immunotherapy.
Pacík
D
D
Urologická klinika FNsP Brno-Bohunice.
Vít
V
V
Turjanica
M
M
D000283:Administration, Intravesical; D001500:BCG Vaccine / Q000008:administration & dosage*; D002277:Carcinoma / Q000473:pathology / Q000628:therapy*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D001749:Urinary Bladder Neoplasms / Q000473:pathology / Q000628:therapy*
D001500:BCG Vaccine
Intravezikální imunoterapie povrchového karcinomu mocového mĕchýre BCG vakcínou.